Citrome L. The ABC’s of dopamine receptor partial agonists - aripiprazole, brexpiprazole and cariprazine: the 15-min challenge to sort these agents out. Int J Clin Pr. 2015;69:1211–20.

Article  CAS  Google Scholar 

Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. pharmacological treatments. Can J Psychiatry. 2016;61:540–60.

Article  PubMed  PubMed Central  Google Scholar 

Blier P, El Mansari M. Serotonin and beyond: therapeutics for major depression. Philos Trans R Soc Lond B Biol Sci. 2013;368:20120536.

Di Matteo V, De Blasi A, Di Giulio C, Esposito E. Role of 5-HT2C receptors in the control of central dopamine function. Trends Pharm Sci. 2001;22:229–32.

Article  PubMed  Google Scholar 

Dremencov E, El Mansari M, Blier P. Noradrenergic augmentation of escitalopram response by risperidone: electrophysiologic studies in the rat brain. Biol Psychiatry. 2007;61:671–8.

Article  CAS  PubMed  Google Scholar 

Dremencov E, EL Mansari M, Blier P. Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area. J Psychiatry Neurosci. 2009;34:223–9.

PubMed  PubMed Central  Google Scholar 

Seager MA, Barth VN, Phebus LA, Rasmussen K. Chronic coadministration of olanzapine and fluoxetine activates locus coeruleus neurons in rats: implications for bipolar disorder. Psychopharmacology. 2005;181:126–33.

Article  CAS  PubMed  Google Scholar 

Chernoloz O, El Mansari M, Blier P. Electrophysiological studies in the rat brain on the basis for aripiprazole augmentation of antidepressants in major depressive disorder. Psychopharmacology. 2009;206:335–44.

Article  CAS  PubMed  Google Scholar 

El Mansari M, Ebrahimzadeh M, Hamati R, Iro CM, Farkas B, Kiss B, et al. Long-term administration of cariprazine increases locus coeruleus noradrenergic neurons activity and serotonin1A receptor neurotransmission in the hippocampus. J Psychopharmacol. 2020;34:1143–54.

Article  CAS  PubMed  Google Scholar 

Higashino K, Ago Y, Umehara M, Kita Y, Fujita K, Takuma K, et al. Effects of acute and chronic administration of venlafaxine and desipramine on extracellular monoamine levels in the mouse prefrontal cortex and striatum. Eur J Pharm. 2014;729:86–93.

Article  CAS  Google Scholar 

Hudson AL, Lalies MD, Silverstone P. Venlafaxine enhances the effect of bupropion on extracellular dopamine in rat frontal cortex. Can J Physiol Pharm. 2012;90:803–9.

Article  CAS  Google Scholar 

Béïque JC, De Montigny C, Blier P, Debonnel G. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat. Neuropharmacology 2000;39:1800–12.

Article  PubMed  Google Scholar 

Furukawa Y, Oguro S, Obata S, Hamza T, Ostinelli EG, Kasai K. Optimal dose of brexpiprazole for augmentation therapy of antidepressant-refractory depression: a systematic review and dose-effect meta-analysis. Psychiatry Clin Neurosci. 2022;76:416–22.

Article  CAS  PubMed  Google Scholar 

Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, et al. Medication augmentation after the failure of SSRIs for depression. N. Engl J Med. 2006;354:1243–52.

Article  CAS  PubMed  Google Scholar 

Keam SJ. Gepirone extended-release: first approval. Drugs. 2023;83:1723–8.

Article  CAS  PubMed  Google Scholar 

Oosterhof CA, El Mansari M, Bundgaard C, Blier P. Brexpiprazole alters monoaminergic systems following repeated administration: an in vivo electrophysiological study. Int J Neuropsychopharmacol. 2015;19:1–12.

Google Scholar 

Szabo ST, Blier P. Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons. Eur J Neurosci. 2001;13:2077–87.

Article  CAS  PubMed  Google Scholar 

Debonnel G, Saint-André É, Hébert C, De Montigny C, Lavoie N, Blier P. Differential physiological effects of a low dose and high doses of venlafaxine in major depression. Int J Neuropsychopharmacol. 2007;10:51–61.

Article  CAS  PubMed  Google Scholar 

Aldosary F, Norris S, Tremblay P, James JS, Ritchie JC, Blier P. Differential potency of venlafaxine, paroxetine, and atomoxetine to inhibit serotonin and norepinephrine reuptake in patients with major depressive disorder. Int J Neuropsychopharmacol. 2022;25:283–92.

Article  CAS  PubMed  Google Scholar 

Turcotte JE, Debonnel G, De Montigny C, Hébert C, Blier P. Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects. Neuropsychopharmacol. 2001;24:511–21.

Article  CAS  Google Scholar 

Vincent S, Bieck PR, Garland EM, Loghin C, Bymaster FP, Black BK, et al. Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles. Circulation. 2004;109:3202–7.

Article  CAS  PubMed  Google Scholar 

Dennis T, L’Heureux R, Carter C, Scatton B. Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat. J Pharmacol Exp Ther. 1987;241:642–9.

CAS  PubMed  Google Scholar 

Sacchetti G, Bernini M, Bianchetti A, Parini S, Invernizzi RW, Samanin R. Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain. Br J Pharmacol. 1999;128:1332–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Béïque JC, Lavoie N, De Montigny C, Debonnel G. Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters. Eur J Pharmacol. 1998;349:129–32.

Article  PubMed  Google Scholar 

Ungless MA, Grace AA. Are you or aren’t you? Challenges associated with physiologically identifying dopamine neurons. Trends Neurosci. 2012;35:422–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vandermaelen CP, Aghajanian GK. Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices. Brain Res. 1983;289:109–19.

Article  CAS  PubMed  Google Scholar 

Marwaha J, Aghajanian GK. Relative potencies of alpha-1 and alpha-2 antagonists in the locus ceruleus, dorsal raphe and dorsal lateral geniculate nuclei: an electrophysiological study. J Pharmacol Exp Ther. 1982;222:287–93.

CAS  PubMed  Google Scholar 

Grace AA, Bunney BS. The control of firing pattern in nigral dopamine neurons: single spike firing. J Neurosci. 1984;4:2866–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hajós M, Sharp T. Burst-firing activity of presumed 5-HT neurones of the rat dorsal raphe nucleus: electrophysiological analysis by antidromic stimulation. Brain Res. 1996;740:162–8.

Article  PubMed  Google Scholar 

El Mansari M, Crnic A, Oosterhof C, Blier P. Long-term administration of the antidepressant vilazodone modulates rat brain monoaminergic systems. Neuropharmacology. 2015;99:696–704.

Article  CAS  PubMed  Google Scholar 

Brunel S, de Montigny C. Validation of the i.t50 method for assessing neuronal responsiveness to microiontophoretic applications: a single-cell recording study. J Pharm Methods. 1988;19:23–30.

Article  CAS  Google Scholar 

Haddjeri N, Blier P, De Montigny C. Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission. J Affect Disord. 1998;51:255–66.

Article  CAS  PubMed  Google Scholar 

Ghanbari R, El Mansari M, Blier P. Electrophysiological effects of the co-administration of escitalopram and bupropion on rat serotonin and norepinephrine neurons. J Psychopharmacol. 2010;24:39–50.